IRadimed

What IRadimed does

IRadimed Corporation (NASDAQ: IRMD) is a US-based medical device company that designs, manufactures, and sells MRI-compatible patient care equipment, including non-magnetic intravenous (IV) infusion pump systems and portable patient vital signs monitors. Founded in 2004 by Roger Susi and headquartered in Winter Springs, Florida, the company serves hospitals, imaging centers, intensive care units, and anesthesiology departments with products specifically engineered to operate safely within MRI magnetic fields up to 30,000 Gauss at the MRI bore. Distribution spans more than 60 countries through direct enterprise field sales in the United States and a network of regional international distributors, including veterinary-focused partners Medequal and Hsien Tai.

The company's core technology centers on proprietary non-magnetic ultrasonic motors and non-ferrous components that enable safe operation in MRI Zone IV environments where conventional electromagnetic devices would pose projectile and image-interference hazards. The product portfolio includes the next-generation MRidium 3870 and legacy 3860+ IV infusion pump systems, the 3880 MRI Patient Monitor (described as the world's first portable MRI-compatible patient monitor), the FMD with TruSense ferrous metal detection system, and proprietary MRI-compatible disposables including IV infusion sets. The 3880 patient monitor integrates wireless ECG, SpO2 via Masimo SET algorithms, non-magnetic respiratory CO2, blood pressure, and temperature monitoring in a portable form factor under 10 lbs. The company maintains a portfolio of granted US, European, and Japanese patents covering MRI-compatible infusion and monitoring technology, plus the MRidium and TruSense trademarks.

IRadimed generates revenue primarily through capital equipment sales of pumps, monitors, and FMD systems, supplemented by recurring revenue from proprietary MRI-compatible disposables (IV infusion sets 1056, 1057, 1058) and subscription services such as the Dose Error Reduction System (DERS) Annual Service License for drug library management and extended warranty contracts. Go-to-market combines direct enterprise sales targeting hospital radiology, ICU, and anesthesiology departments domestically with authorized regional distributors internationally. The company uplisted to NASDAQ in June 2024 from OTC Markets, reported $83.8 million in full-year 2025 revenue (14% YoY growth) with 18 consecutive quarters of record revenue, ended Q3 2025 with $56.5 million in cash and no debt, and is guiding to $91-96 million for full-year 2026.

Name

IRadimed

Legal name

IRADIMED CORPORATION

Website

https://iradimed.com

Company type

Public

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

IRadimed (NASDAQ: IRMD) designs, manufactures, and sells non-magnetic MRI-compatible IV infusion pumps, portable patient vital signs monitors, and ferrous metal detection systems for hospitals, ICUs, anesthesiology departments, and veterinary clinics across 60+ countries.

Ownership category

akta.pro rank

Product category

MRI-Compatible Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Infusion Pumps (Ambulatory/Stationary) (HLAHAIAF)

akta.pro secondary industry

IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets) (HLAMAFAG)

Keywords

• MRI-compatible infusion pumps
• MRI patient monitoring systems
• Non-magnetic medical devices
• Ferrous metal detection
• MRI clinical accessories

Headquarters

HQ city

Winter Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. MRI-Compatible Medical Devices: Sale of MRI-compatible IV infusion pumps (MRidium 3870, 3860+) and patient vital signs monitoring systems (3880) as capital equipment to hospitals and imaging centers. Revenue recognized upon delivery.
2. Accessories and Disposables: Sale of MRI-compatible IV infusion sets (1056, 1057, 1058) and clinical accessories designed exclusively for use with MRidium MRI Infusion systems. Recurring revenue from consumables used in procedures.
3. Extended Warranty and Service Contracts: Extended warranty services and DERS Annual Service License for drug library management, with automatic renewal terms for ongoing support and updates.
4. Training Services: Purchased in-service training services that must be completed within 90 days of product delivery, included in product terms.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

IRadimed designs, manufactures, and sells non-magnetic MRI-compatible IV infusion pump systems (MRidium 3870 and 3860+), the 3880 MRI patient monitor, and the FMD with TruSense ferrous metal detector, along with proprietary MRI IV infusion sets and accessories. These devices use patented non-ferrous ultrasonic motors and proprietary algorithms to safely operate within MRI magnetic fields up to 30,000 Gauss for hospitals, imaging centers, ICUs, anesthesiology departments, and veterinary clinics.

Differentiator

Problem solved

Functional benefit

Products and services

• MRidium 3870 MRI IV Infusion Pump System Next-generation MRI-compatible syringe infusion pump with non-magnetic ultrasonic motor designed for safe operation within MRI Zone IV; serves hospital radiology, ICU, and anesthesiology teams delivering IV medications at the MRI bore.
• 3880 MRI Patient Monitor Portable, non-magnetic MRI patient monitor with wireless ECG, SpO2 using Masimo algorithms, non-magnetic CO2, blood pressure, and temperature monitoring for ICU and anesthesia patients during MRI procedures.
• MRidium 3860+ MRI IV Infusion Pump System MRI-compatible non-magnetic infusion pump system allowing continuous delivery of medications within the MRI suite for sedated and critical-care patients.
• FMD Smart MRI Ferrous Metal Detection System with TruSense

Quantifiable outcome

• Enables MRI diagnosis changes in therapy and management for up to 70% of critically ill patients
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered strategic, regional and core.

• MasimostrategicTechnology or Integration · 2 September 2025Masimo founder Joe Kiani appointed to IRadimed Board of Directors in September 2025. Masimo is renowned for medical technology innovation including SET pulse oximetry algorithms used in IRadimed's 3880 MRI patient monitor.
• MedequalregionalChannel Partner/ Reseller/ DistributorAuthorized distributor for IRadimed non-magnetic MRI solutions in the Philippines, participating in the 78th Annual Philippine College of Radiology Conference.
• Hsien TairegionalChannel Partner/ Reseller/ DistributorAuthorized distributor for IRadimed non-magnetic patient monitors and IV infusion pumps in Taiwan, participating in the 59th Annual Meeting of TWSRT and International Conference of Medical Imaging.
• Global Distribution NetworkcoreChannel Partner/ Reseller/ DistributorRegional distributors covering 60+ countries across Americas, Europe, Middle East, Africa, Asia, and Oceania markets.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• ICU Medical: ICU Medical is a leading manufacturer of IV infusion pumps, including the Plum 360 and LifeShield systems, and acquired Smiths Medical in 2022. It is the most direct publicly traded peer to IRadimed in the infusion pump space, though ICU Medical's portfolio is broader and not MRI-specific.
• B. Braun Medical: B. Braun manufactures the Infusomat Space and Perfusor Space infusion pump systems used in hospitals globally. It is a direct competitor in standard infusion and has the engineering depth to enter the MRI-compatible segment.
• Philips Healthcare: Philips sells the MR400 MRI patient monitor, which IRadimed explicitly benchmarks against with its 3880 monitor. Philips is the closest direct competitor in MRI patient monitoring and also manufactures MRI scanners and broader patient monitoring portfolios.

Broad incumbents

• Becton Dickinson (BD): BD produces the Alaris, BD Pyxis, and other infusion pump platforms sold to hospitals worldwide. As a diversified medical device incumbent with deep hospital relationships, BD represents both a peer and a potential competitor if it elects to develop an MRI-compatible infusion platform.
• Baxter International: Baxter's Sigma Spectrum and Novum infusion pumps are widely deployed in U.S. hospitals. While not MRI-specific, Baxter competes for the same hospital infusion budgets and could pursue MRI-compatible variants using its R&D scale.
• GE Healthcare: GE Healthcare manufactures MRI scanners, anesthesia machines, and patient monitors used in MRI environments. As the dominant MRI system vendor, it has unique leverage to bundle its own MRI-compatible accessories against IRadimed's standalone offerings.

Emerging players

• Masimo: Masimo's SET pulse oximetry algorithms are integrated into IRadimed's 3880 monitor, and Masimo founder Joe Kiani joined IRadimed's board in September 2025. Masimo is a leader in non-invasive patient monitoring and is a natural adjacent/partner in the MRI monitoring category.
• Terumo Medical: Terumo manufactures infusion systems and is expanding its hospital presence in the Americas. While not focused on MRI-compatible devices, it is a relevant peer for infusion consumables and pumps in critical care settings.
• Fresenius Kabi: Fresenius Kabi manufactures the Ivenix infusion pump platform and is a major player in clinical nutrition and IV therapy. Comparable to IRadimed in serving hospital infusion workflows, though focused on non-MRI environments.
• Mindray: Mindray produces a broad portfolio of patient monitoring and infusion pump devices sold internationally, often at lower price points than Western OEMs. It is an emerging peer with growing presence in U.S. and European hospital accounts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/100849206736831
• LinkedInlinkedin.com/company/iradimed

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IRadimed